Read more

March 25, 2022
1 min read
Save

At-home testing tripled during omicron, but data show disparities in use

At-home testing for COVID-19 more than tripled during the omicron wave in the United States, but there were disparities in the tests’ use, according to a study published Friday in MMWR.

Data showed at-home testing was less common among people who were older, Black, had a lower income and a high school education level or less, Benjamin Rader, MPH, a graduate research fellow at Boston Children’s Hospital and the Boston University School of Public Health, and colleagues reported.

Holding COVID home test
At-home COVID-19 testing was more common during the omicron vs. the delta wave. Source: Adobe Stock.

They collected data from more than 418,000 adult respondents to an online survey from Aug. 23 through March 12. The data “were used to estimate self-reported at-home test use over time, and by demographic characteristics, geography, symptoms/syndromes, and reasons for testing,” the researchers explained.

At-home testing among respondents who self-reported symptoms consistent with COVID-19 rose from 5.7% to 20.1% between the delta-predominant period of Aug. 23 to Dec. 11 and the omicron-predominant period of Dec. 19 through March 12, which also coincided with the U.S. government beginning to distribute free at-home tests, including through the mail. The two most reported reasons for testing were exposure (39.4%) and symptoms (28.9%).

The researchers found that white respondents (5.9%) were more than twice as likely to use a home test as Black respondents (2.8%). There also was a wide difference between test use among adults aged 30 to 39 years (6.4%) and adults aged 75 years or older (3.6%). Households with an income of at least $150,000 tested at twice the rate as those with incomes between $50,000 and $75,000 (9.5% vs. 4.7%). The same was true for respondents with a higher education level — 8.4% with post-graduate degrees used the tests vs. 3.5% with a high school education or less.

“Rapid, at-home diagnostic testing can provide convenient access to assessment of SARS-CoV-2 infection,” Rader and colleagues wrote. “Providing reliable and low-cost or free at-home test kits to underserved populations with otherwise limited access to COVID-19 testing could assist with continued prevention efforts.”